Advertisement

Mental Health

The Department of Labor is sharpening its enforcement focus on health plans’ compliance with federal mental health parity requirements, including restrictions that could affect access to behavioral healthcare. The department’s Employee Benefits Security Administration issued updated enforcement guidance Sept. 8…

Suicide-related emergency department visits among children increased 74% from 2016 to 2022, according to a study published Sept. 3 in Annals of Emergency Medicine. The study represented more than 5 million pediatric mental health ED visits in the U.S. Here…

Americans are more likely to say AI chatbots hurt rather than help people who use them for support with loneliness, depression or stress, according to an Aug. 25 Pew Research Center report. The center surveyed 3,488 U.S. adults from June…

Advertisement

OpenAI introduced ChatGPT for Teens with built-in safeguards aimed at reducing exposure to potentially harmful or developmentally inappropriate content for users under 18.  The protections address higher-risk areas including self-harm, eating disorders, violence, dangerous activities and explicit sexual or graphic…

Access to mental healthcare remains out of reach for millions of Americans, with some states facing more severe shortages of mental health professionals than others, new federal data shows. The Health Resources and Services Administration’s Bureau of Health Workforce published…

Just under half of full-time U.S. physicians report burnout at some point and one-fifth report depression, according to a Medscape report published Aug. 3.  The report is based on survey insights from 5,159 physicians in 29 specialties collected between Jan.…

As health systems continue to grow through mergers and acquisitions, sustaining physician well-being efforts has become increasingly complex. Leaders at Philadelphia-based Jefferson Health recently shared how the system has integrated clinician well-being into operations, leadership and organizational culture, the American…

The FDA approved Simtriyo (centanafadine), making it the first and only approved norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients aged 6 years and older weighing at least 20…

Advertisement